377 related articles for article (PubMed ID: 18505176)
1. Silver nanoparticles inhibit hepatitis B virus replication.
Lu L; Sun RW; Chen R; Hui CK; Ho CM; Luk JM; Lau GK; Che CM
Antivir Ther; 2008; 13(2):253-62. PubMed ID: 18505176
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays.
Zhou T; Guo H; Guo JT; Cuconati A; Mehta A; Block TM
Antiviral Res; 2006 Nov; 72(2):116-24. PubMed ID: 16780964
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
[TBL] [Abstract][Full Text] [Related]
5. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
McMillan JS; Shaw T; Angus PW; Locarnini SA
Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
Shaw T; Mok SS; Locarnini SA
Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx].
Kim JW; Lee SH; Park YS; Jeong SH; Kim N; Lee DH
Korean J Hepatol; 2009 Mar; 15(1):15-24. PubMed ID: 19346782
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
12. Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro.
Huang RL; Chen CC; Huang YL; Hsieh DJ; Hu CP; Chen CF; Chang C
Hepatology; 1996 Sep; 24(3):508-15. PubMed ID: 8781315
[TBL] [Abstract][Full Text] [Related]
13. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication.
Romero MR; Serrano MA; Efferth T; Alvarez M; Marin JJ
Planta Med; 2007 Jun; 73(6):552-8. PubMed ID: 17458779
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the replication of hepatitis B virus in vitro by emodin.
Shuangsuo D; Zhengguo Z; Yunru C; Xin Z; Baofeng W; Lichao Y; Yan'an C
Med Sci Monit; 2006 Sep; 12(9):BR302-6. PubMed ID: 16940925
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
[TBL] [Abstract][Full Text] [Related]
16. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells.
Sun RW; Chen R; Chung NP; Ho CM; Lin CL; Che CM
Chem Commun (Camb); 2005 Oct; (40):5059-61. PubMed ID: 16220170
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro.
Xiang DX; Chen Q; Pang L; Zheng CL
J Virol Methods; 2011 Dec; 178(1-2):137-42. PubMed ID: 21945220
[TBL] [Abstract][Full Text] [Related]
18. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity.
Hu Y; Cheng X; Cao F; Huang A; Tavis JE
Antiviral Res; 2013 Sep; 99(3):221-9. PubMed ID: 23796982
[TBL] [Abstract][Full Text] [Related]
19. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
Xu J; Wang J; Deng F; Hu Z; Wang H
Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
[TBL] [Abstract][Full Text] [Related]
20. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]